GENE ONLINE|News &
Markets & Deals
AbbVie Bets $5.6 Billion on PD-1×VEGF Bispecifics, Licensing RemeGen’s RC148 to Expand Its Oncology Arsenal
2026-01-13
Japan’s Eisai and U.S.-Based Nuvation Bio Secure Europe, Middle East Rights for Lung Cancer Drug in €195M Deal
2026-01-13
From Pipeline to Payday: The Rare Disease Assets Most Likely to Spark a 2026 M&A Land-Grab
2026-01-13
First-of-Its-Kind AI Drug Discovery Lab: NVIDIA, Eli Lilly Announce $1B Investment at J.P. Morgan Healthcare
2026-01-12
Rakuten Medical Closes $100 Million Series F to Push Lead Cancer Therapy Toward FDA Review
2026-01-09
Early 2026 Biotech Fundraising: Parabilis and EpiBiologics Secure Major Rounds to Advance Oncology Pipelines
2026-01-09
DISCO Pharmaceuticals and Amgen Ink Exclusive License Deal to Advance Surfaceome-Targeted Cancer Therapies
2026-01-07
Evergreen VC Fund Drives Cross-sector Synergy, Connecting Global and Taiwanese Biotech Ecosystems
2025-12-10
Navigating the Valley of Death: How Biotech Startups Can Survive Venture Capital Realities
2025-11-26
From Laboratory to Deal-making Table: Navigating Challenges in Global Business Development and Due Diligence
2025-11-25
South Korea’s Celltrion Inks $744 Million Deal with U.S. Biotech, Eyeing Autoimmune Drug Market
2025-11-06
Decoding the Global Biopharma Network: How Data-Driven Partnering Is Redefining Japan’s Next Move
2025-10-14
LATEST
Gut Microbiome Composition Predicts Long-term Cardiometabolic Health Outcomes in Diverse Urban Populations
2026-03-12
NVIDIA Ahead of GTC 2026: Markets Focus on Data Center Strength, PC Expansion, and the Next Technical Breakout
2026-03-12
Global and APAC Biopharma Watch: Capital Raising, Clinical Expansion, and Industry Moves in Focus
2026-03-12
EVENT
2026-04-09
4th Cell & Gene Therapy Innovation & Access Congress: Asia (Media Partnership)
Seoul, South Korea
